Temple Therapeutics spins off orthobiologics company

Temple Therapeutics, a women’s health company, launched a spinoff venture for orthopedic sports medicine, according to a Sept. 9 news release.  

Advertisement
By: Carly Behm

Temple OrthoBiologics aims to address issues with scar tissue in joints, the news release said. The company’s flagship product is TX-33, which is designed for muscle recovery and repair in athletes. The product aims to prevent scar tissue from forming after an injury or surgery.

The company’s research and development hub is in Belgium and has partnerships in the U.S., Netherlands and Canada.

Healthcare revenue recoveries face sustained margin pressure — 3 strategies to improve recovery

Recommended Whitepaper

Advertisement

Next Up in Biologics

  • Auragens launches orthobiologics division

    Regenerative medicine company Auragens has opened an orthobiologics division.  Orthopedic surgeon Abdiel Ortiz, MD, will lead the new division, which…

    By: Cameron Cortigiano

  • 6 ways biologics is advancing in spine

    So far this year, medtech companies and academic institutions are making key strides in spine biologics. From new product launches…

    By: Carly Behm
Advertisement

Comments are closed.